➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Express Scripts
McKinsey
McKesson

Last Updated: January 16, 2021

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has thirteen approved drugs.



Summary for Ingenus Pharms Llc
US Patents:0
Tradenames:13
Ingredients:13
NDAs:13

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 210947-001 Feb 18, 2020 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc CABERGOLINE cabergoline TABLET;ORAL 204735-001 Aug 1, 2018 AB RX No Yes   Start Trial   Start Trial
Ingenus Pharms Llc OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 207562-001 Oct 16, 2018 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-001 Aug 31, 2017 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc PALONOSETRON HYDROCHLORIDE palonosetron hydrochloride INJECTABLE;INTRAVENOUS 208789-001 May 22, 2020 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
Express Scripts
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.